FDA Grants Orphan Drug Status to Soin Therapeutics for Low Dose Naltrexone (LDN) to Treat Complex Regional Pain Syndrome (CRPS) apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
News Category Global Banking & Finance Reviews Istari Oncology Announces FDA Grants Orphan Drug Designation for PVSRIPO for the Treatment of Advanced Melanoma Istari Oncology Announces FDA Grants Orphan Drug Designation for PVSRIPO for the Treatment of Advanced Melanoma Istari Oncology, Inc., a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for PVSRIPO for the treatment of advanced melanoma (stage IIB-IV). PVSRIPO is a novel viral immunotherapy, based on the Sabin type 1 polio vaccine, that activates a patients innate and adaptive immune system to facilitate an anti-tumor response and establish long-term immunologic memory to help prevent the cancers return.
Novadip Biosciences Receives Rare Paediatric Disease Priority Review and Orphan Disease Designation Rare Paediatric Disease Priority Review and Orphan Disease Designation Dual designations granted for NVD-003 for the Treatment of Congenital Pseudarthrosis of the Tibia a serious and debilitating condition that primarily affects children Walloon Region Government to support the development of treatments at Novadip with €9.4 million of non-dilutive funding Walloon Region Minister Willy Borsus to visit Novadip Biosciences in Mont-Saint-Guibert today Mont-Saint-Guibert, Dec 23 2020 (GlobeNewswire) - Novadip Biosciences ( Novadip ), a clinical stage company developing treatments to regenerate impaired tissues in patients with significant unmet medical needs, today announces that the U.S. Food and Drug Administration (FDA) has granted Rare Paediatric Disease designation and Orphan Drug designation for NVD-003, a cell therapy for the treatment of Congenital Pseudarthrosis of the Tibia ( CPT ), a rare but serious and debilitating condition, that primarily affects children with devastating consequences.